NO982843L - 2,7-Substituerte oktahydro-pyrrol£1,2-a|pyrazin-derivater - Google Patents

2,7-Substituerte oktahydro-pyrrol£1,2-a|pyrazin-derivater

Info

Publication number
NO982843L
NO982843L NO982843A NO982843A NO982843L NO 982843 L NO982843 L NO 982843L NO 982843 A NO982843 A NO 982843A NO 982843 A NO982843 A NO 982843A NO 982843 L NO982843 L NO 982843L
Authority
NO
Norway
Prior art keywords
apyrazine
pyrrole
derivatives
substituted octahydro
octahydro
Prior art date
Application number
NO982843A
Other languages
English (en)
Other versions
NO982843D0 (no
NO309936B1 (no
Inventor
Mark A Sanner
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO982843D0 publication Critical patent/NO982843D0/no
Publication of NO982843L publication Critical patent/NO982843L/no
Publication of NO309936B1 publication Critical patent/NO309936B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO982843A 1995-12-21 1998-06-19 2,7-Substituerte oktahydro-pyrrol[1,2-a]pyrazin-derivater, anvendelse derav, farmasøytisk preparat, samt mellomprodukter for fremstilling av derivatene NO309936B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US898895P 1995-12-21 1995-12-21
PCT/IB1996/001192 WO1997023482A1 (en) 1995-12-21 1996-11-06 2,7-substituted octahydro-pyrrolo[1,2-a]pyrazine derivatives

Publications (3)

Publication Number Publication Date
NO982843D0 NO982843D0 (no) 1998-06-19
NO982843L true NO982843L (no) 1998-06-19
NO309936B1 NO309936B1 (no) 2001-04-23

Family

ID=21734893

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982843A NO309936B1 (no) 1995-12-21 1998-06-19 2,7-Substituerte oktahydro-pyrrol[1,2-a]pyrazin-derivater, anvendelse derav, farmasøytisk preparat, samt mellomprodukter for fremstilling av derivatene

Country Status (33)

Country Link
US (1) US5714487A (no)
EP (1) EP0874849B1 (no)
JP (1) JP3204456B2 (no)
KR (1) KR100286786B1 (no)
CN (1) CN1061350C (no)
AR (1) AR005102A1 (no)
AT (1) ATE205846T1 (no)
AU (1) AU704578B2 (no)
BR (1) BR9612246A (no)
CA (1) CA2240594C (no)
CO (1) CO4480107A1 (no)
CZ (1) CZ192998A3 (no)
DE (1) DE69615404T2 (no)
DK (1) DK0874849T3 (no)
ES (1) ES2161377T3 (no)
GR (1) GR3037060T3 (no)
GT (1) GT199600101A (no)
HU (1) HUP9900611A3 (no)
IL (1) IL124453A0 (no)
MA (1) MA26413A1 (no)
MX (1) MX9805088A (no)
NO (1) NO309936B1 (no)
NZ (1) NZ320537A (no)
PE (1) PE25998A1 (no)
PL (1) PL327539A1 (no)
PT (1) PT874849E (no)
RU (1) RU2162470C2 (no)
SI (1) SI0874849T1 (no)
TN (1) TNSN96164A1 (no)
TR (1) TR199801161T2 (no)
TW (1) TW479058B (no)
WO (1) WO1997023482A1 (no)
ZA (1) ZA9610781B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281216B1 (en) * 1998-02-09 2001-08-28 Duphar International Research B.V. 2-aminoquinoline derivatives having d4-agonistic activity
EP0982030A3 (en) 1998-08-17 2000-05-10 Pfizer Products Inc. 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
CN1176086C (zh) * 1999-02-05 2004-11-17 法玛西雅厄普约翰美国公司 制备(5R)-甲氨基-5,6-二氢-4H-咪唑并[4,5,1-ij]喹啉-2(1H)-酮的方法
DE60011858T2 (de) 1999-09-10 2005-08-25 Mitsubishi Jidosha Kogyo K.K. Stufenloses Getriebe
ATE247110T1 (de) * 1999-09-14 2003-08-15 Aventis Pharma Inc Benzisoxazolyl-, pyridoisoxazolyl- und benzthienyl-phenoxy derivate als d4 antagonisten
US7253165B2 (en) 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
DE60211186T2 (de) * 2001-09-19 2007-01-18 Merck Patent Gmbh Neue verwendung substituierter aminomethylchromane
TW200801005A (en) * 2005-08-15 2008-01-01 Astrazeneca Ab Acetylenic piperazines as metabotropic glutamate receptor antagonists
US7728031B2 (en) * 2006-02-24 2010-06-01 Abbott Laboratories Octahydro-pyrrolo[3,4-b]pyrrole derivatives
WO2013049164A1 (en) * 2011-09-29 2013-04-04 Abbvie Inc. SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS
CN119112895A (zh) 2018-09-04 2024-12-13 康蒂内乌姆医疗公司 毒蕈碱性乙酰胆碱m1受体拮抗剂
IL326597A (en) 2019-10-07 2026-04-01 Contineum Therapeutics Inc Muscarinic acetylcholine m1 receptor antagonists
US11752149B2 (en) 2019-12-02 2023-09-12 Pipeline Therapeutics, Inc. Muscarinic acetylcholine M1 receptor antagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4400511A (en) * 1982-05-07 1983-08-23 American Home Products Corporation 2-Substituted octahydropyrrolo(1,2-A)-pyrazine-3-carboxylic acids
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
US5122515A (en) * 1990-06-19 1992-06-16 Smith Ross C Nutrient composition containing dipeptides and method for administering the same
JP3058945B2 (ja) * 1990-10-26 2000-07-04 三共株式会社 Ｎ−（３，３−ジ置換アクリロイル）ピペラジン誘導体
EP0665840A1 (en) * 1992-10-23 1995-08-09 MERCK SHARP & DOHME LTD. Dopamine receptor subtype ligands
AU678186B2 (en) * 1992-10-23 1997-05-22 Merck Sharp & Dohme Limited Dopamine receptor subtype ligands
EP0775118B1 (en) * 1994-08-05 2003-06-04 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
CZ285090B6 (cs) * 1994-09-30 1999-05-12 Pfizer Inc. 2,7-Disubstituovaný oktahydro-1H-pyrido-[1,2-a]pyrazinové deriváty a farmaceutické prostředky na jejich bázi
US5576314A (en) * 1994-12-12 1996-11-19 Allelix Biopharmaceuticals Inc. Bicyclic nonane and decane compounds having dopamine receptor affinity

Also Published As

Publication number Publication date
CA2240594C (en) 2001-07-24
GR3037060T3 (en) 2002-01-31
SI0874849T1 (no) 2001-12-31
CZ192998A3 (cs) 1999-05-12
US5714487A (en) 1998-02-03
GT199600101A (es) 1998-06-12
CN1061350C (zh) 2001-01-31
AU7328096A (en) 1997-07-17
WO1997023482A1 (en) 1997-07-03
PL327539A1 (en) 1998-12-21
CA2240594A1 (en) 1997-07-03
NO982843D0 (no) 1998-06-19
MX9805088A (es) 1998-10-31
NZ320537A (en) 1999-03-29
JP3204456B2 (ja) 2001-09-04
JPH11508920A (ja) 1999-08-03
ES2161377T3 (es) 2001-12-01
NO309936B1 (no) 2001-04-23
ZA9610781B (en) 1998-06-22
PE25998A1 (es) 1998-05-19
CN1205704A (zh) 1999-01-20
PT874849E (pt) 2002-01-30
IL124453A0 (en) 1998-12-06
CO4480107A1 (es) 1997-07-09
AR005102A1 (es) 1999-04-14
ATE205846T1 (de) 2001-10-15
EP0874849B1 (en) 2001-09-19
BR9612246A (pt) 1999-07-13
DE69615404T2 (de) 2002-06-06
TW479058B (en) 2002-03-11
EP0874849A1 (en) 1998-11-04
TR199801161T2 (xx) 1998-10-21
RU2162470C2 (ru) 2001-01-27
DE69615404D1 (de) 2001-10-25
HUP9900611A2 (hu) 1999-08-30
TNSN96164A1 (fr) 2005-03-15
HUP9900611A3 (en) 2000-09-28
AU704578B2 (en) 1999-04-29
KR100286786B1 (ko) 2001-04-16
KR19990076616A (ko) 1999-10-15
DK0874849T3 (da) 2001-11-19
MA26413A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
NO974595D0 (no) Imidazo£1,2-a|pyridin-derivater
NL300214I2 (nl) Chinazolinederivaten.
DE69611361D1 (de) Chinazolin-derivate
NO974103L (no) Arylsulfonylaminohydroksamsyre-derivater
DE69610698D1 (de) Chinazolin-derivate
PT833828E (pt) Derivados de rapamicina
BR9611834A (pt) Derivados de oximetóxi-3-aril-pirona
TR199600883A2 (tr) Pürin-6-on türevleri.
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
NO982843D0 (no) 2,7-Substituerte oktahydro-pyrrol£1,2-a|pyrazin-derivater
DE69601527D1 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
TR199600715A2 (tr) Kefalosforin türevleri.
FI971310L (fi) 2,7-substituoituja oktahydro-1H-pyrido/1,2-a/pyratsiinijohdannaisia
DE69628200D1 (de) Diarylalkenylamin-derivate
DE69627830D1 (de) Pyrazol-derivate
TR199600064A2 (tr) 4-amino-benzoilguanidin-türevleri.
DE59610106D1 (de) Fluorbenzylether-Derivate
ATE177102T1 (de) Chromanderivate
ATE225347T1 (de) Aza-anthracyclinone-derivate
DE59607055D1 (de) 4-Mercapto-benzoylguanidin-Derivate
DE69620514D1 (de) 5-aminoflavon-derivate
BR9609892A (pt) Derivados de imidazopiridina
ATA45796A (de) Lysin-prolin-derivate
FI970827L (fi) Uudet tiatsolo 3,2-a/kinoliini - ja -nafthyridiinijohdannaiset